Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Links relacionados
Similares en SciELO
Compartir
Revista argentina de cardiología
versión On-line ISSN 1850-3748
Resumen
ABUD, Atilio M. et al. Retrospective Analysis of Patients with Brugada Syndrome and Implantable Cardioverter Defibrillator. Rev. argent. cardiol. [online]. 2014, vol.82, n.1, pp.21-25. ISSN 1850-3748.
Introduction The Brugada syndrome is an inherited, electrical anomaly, with increased risk of sudden cardiac death. Automatic cardioverter defibrillators are the only effective treatment to prevent sudden cardiac death, while therapy management in asymptomatic patients is still controversial. Objectives The aims of the study were to evaluate the incidence and causes of appropriate and inappropriate shocks and the complications related to the device, and to identify the relation of clinical and electrophysiological study variables with the incidence of appropriate shocks. Methods This was a single-center, retrospective registry of patients with Brugada syndrome, with type-1 electrocardiographic pattern, either spontaneous or induced by ajmaline infusion, who were recipients of automatic implantable cardioverter defibrillator. Results Twenty-one patients were included in the study; 18 were males, and average age was 40 years. The device was indicated due to the following symptoms: nocturnal agonal respiration, syncope and aborted cardiac arrest, or positive electrophysiology study in asymptomatic patients. There were no deaths during follow-up of 88 months, and the yearly rate of appropriate shocks was 1.9%, below that of inappropriate shocks (7.5%). Ten patients presented complications including device infection and psychiatric disorders. The only variable significantly related with the presence of appropriate shocks was history of fibrillation and atrial flutter. Conclusions A low yearly rate of appropriate shocks was observed. The difficulties in risk stratification, the high incidence of inappropriate shocks and the high frequency of complications indicate need of careful patient selection for the implantation of these devices until more reliable predictors of arrhythmic risk are found.
Palabras clave : Brugada Syndrome; Tachycardia; Ventricular; Defibrillators; implantable.